Tolmar Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TOLMAR, and what generic alternatives to TOLMAR drugs are available?
TOLMAR has eight approved drugs.
There are twelve US patents protecting TOLMAR drugs. There is one tentative approval on TOLMAR drugs.
There are thirty-seven patent family members on TOLMAR drugs in eighteen countries and two supplementary protection certificates in two countries.
Summary for Tolmar
| International Patents: | 37 |
| US Patents: | 12 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 8 |
| Patent Litigation for Tolmar: | See patent lawsuits for Tolmar |
Drugs and US Patents for Tolmar
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolmar | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 8,778,916 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Tolmar | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | SYRUP;ORAL | 090054-001 | Nov 15, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Tolmar | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 10,617,696 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Tolmar | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 11,331,325 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tolmar | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 11,179,402 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Tolmar | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | 8,241,664 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Tolmar
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 9,539,333 | ⤷ Sign Up |
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | 4,938,763 | ⤷ Sign Up |
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | 6,626,870 | ⤷ Sign Up |
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | 8,486,455 | ⤷ Sign Up |
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 8,486,455 | ⤷ Sign Up |
| Tolmar | ELIGARD KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | 5,599,552 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Tolmar Drugs
Supplementary Protection Certificates for Tolmar Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0162036 | C300028 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929 |
| 0162036 | 2000C/032 | Belgium | ⤷ Sign Up | PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
